Aeglea BioTherapeutics (AGLE) Prices 3.75M Share Common Offering at $8/Sh and Prices 3.75M Warrant Offering at $7.99/Unit
February 6, 2019 5:48 AM
Aeglea BioTherapeutics, Inc., (NASDAQ: AGLE) a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
